Genesis Research Group Appoints Tim Wright as Executive Vice President, Access and Pricing
July 1, 2025 |
Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the appointment of Tim Wright as Executive Vice President, Access and Pricing. He will serve as a member of the company’s Executive Leadership Team and lead the Access & Pricing business unit.
Tim Wright brings more than 30 years of comprehensive biopharmaceutical industry experience, including 12 years in direct industry roles and 18 years in specialized pricing and market access (P&MA) consulting. His appointment reflects Genesis Research Group’s continued commitment to deepening its expertise and enhancing the value it delivers to clients navigating today’s complex market access landscape.
David Miller, Chief Executive Officer of Genesis Research Group, said: “Tim’s extensive global experience and proven track record in access and pricing strategy will be invaluable as we continue to deliver innovative solutions for our clients facing increasingly complex market challenges. We are delighted to add such an accomplished biopharmaceutical leader to our executive team and warmly welcome him to Genesis Research Group.”
Over a distinguished career, Tim Wright has successfully managed multidisciplinary teams across major markets including the United States, United Kingdom, Europe, and Asia. An economist by training, he has directed more than 1,000 client engagements spanning major therapeutic areas, including rare disease indications—a breadth of expertise that uniquely positions him to drive strategic initiatives and deliver innovative solutions for the company’s client portfolio.
Tim Wright, Executive Vice President, Access and Pricing commented: ‘I am so pleased to have joined the team at this important time in the bioscience sector. Since entering the industry 30 years ago, I’ve not seen greater pressure on clients. The squeeze on prices and reticence of evaluation bodies to update methodologies to recognise full value both present huge external challenges. There is also significant internal pressure to fill portfolio gaps, accelerate access at the sub-national level, and access revenues from less traditional markets. We are in the absolute sweet spot to partner with our clients – highly experienced methodologists, scientists and strategists combined with technology and a real desire across the whole team to excel in all we do. I am delighted to be leading the A&P team in our partnerships with clients large and small.’
Tim Wright’s appointment reflects Genesis Research Group’s commitment to strengthening its capabilities and expanding its service offerings to meet the growing demands of the biopharmaceutical sector. As the leader of the Access & Pricing business unit, Tim Wright succeeds Dr. Kuldeep Kumar Singh, who continues to work with Genesis in a part-time advisory role.
For further details of Genesis Research Group’s Access and Pricing services, please visit their website or contact solutions@genesisrg.com.
This content was provided by Genesis Research Group
Company Details
Latest Content from Genesis Research Group
Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.
In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group’s recent expansion of its real-world data…
Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program
Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural…
Genesis Research Group survey discovers how payers are responding to Maximum Fair Prices (MFPs) under the Inflation Reduction Act
To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business approaches, Genesis Research Group employed their RPR stakeholder engagement platform and vetted stakeholder network to…
Genesis Research Group ISPOR Europe presentation ‘Planning with Insights: Even the Best Economic Models Need Validation’ features in scientific publication
We are pleased to share that The Evidence Base have carried out a ‘deep dive’ into a Genesis Research Group presentation on economic modeling in healthcare and harnessing stakeholder insights…
Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online
Genesis Research Group’s poster ‘Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey’ was recently named as…
Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group
A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition…
Genesis Research Group unveils enhanced US market access data analytics
Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities…
Assessing opportunities for manufacturers to communicate the value of therapies to oncology clinical pathway (OCP) developers
Based on insights from 15 U.S. payers and providers, this white paper explores how manufacturers can effectively engage oncology clinical pathway (OCP) developers.
Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program
Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to supporting life…
Alice Beer of ITN Business recently interviewed David W. Miller, CEO of Genesis Research Group, on ‘Advancing Healthcare’
ITN Business invited Genesis Research Group to contribute to a news style programme ‘Advancing Healthcare’ featuring key opinion leaders in the healthcare sector. Our CEO David W. Miller was one…